Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Plos One
|
September 3, 2010
SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy
Kathryn J Swoboda, Charles B Scott, Thomas O Crawford, et al.
Human Genetics
|
February 22, 2019
Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype
Corey Ruhno, Vicki L McGovern, Matthew R Avenarius, et al.
Plos One
|
July 15, 2011
SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy
John T Kissel, Charles B Scott, Sandra P Reyna, et al.
Muscle & Nerve
|
May 18, 2013
SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy
John T Kissel, Bakri Elsheikh, Wendy M King, et al.
Cancer Research
|
October 3, 2007
Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients
Heather Hampel, Jenny Panescu, Janet Lockman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer
Elaine T Lam, Matthew D Ringel, Richard T Kloos, et al.
Cancer Research
|
August 4, 2006
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients
Heather Hampel, Wendy Frankel, Jenny Panescu, et al.
Leukemia
|
August 3, 2022
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
Nikolaus Jahn, Ekaterina Jahn, Maral Saadati, et al.
The Journal of Clinical Investigation
|
October 8, 2019
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment
Daniel M Ramos, Constantin d'Ydewalle, Vijayalakshmi Gabbeta, et al.
Muscle & Nerve
|
August 24, 2017
Clinical trial of L-Carnitine and valproic acid in spinal muscular atrophy type I
Kristin J Krosschell, John T Kissel, Elise L Townsend, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Plos One
|
September 3, 2010
SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy
Kathryn J Swoboda, Charles B Scott, Thomas O Crawford, et al.
Human Genetics
|
February 22, 2019
Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype
Corey Ruhno, Vicki L McGovern, Matthew R Avenarius, et al.
Plos One
|
July 15, 2011
SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy
John T Kissel, Charles B Scott, Sandra P Reyna, et al.
Muscle & Nerve
|
May 18, 2013
SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy
John T Kissel, Bakri Elsheikh, Wendy M King, et al.
Cancer Research
|
October 3, 2007
Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients
Heather Hampel, Jenny Panescu, Janet Lockman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer
Elaine T Lam, Matthew D Ringel, Richard T Kloos, et al.
Cancer Research
|
August 4, 2006
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients
Heather Hampel, Wendy Frankel, Jenny Panescu, et al.
Leukemia
|
August 3, 2022
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
Nikolaus Jahn, Ekaterina Jahn, Maral Saadati, et al.
The Journal of Clinical Investigation
|
October 8, 2019
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment
Daniel M Ramos, Constantin d'Ydewalle, Vijayalakshmi Gabbeta, et al.
Muscle & Nerve
|
August 24, 2017
Clinical trial of L-Carnitine and valproic acid in spinal muscular atrophy type I
Kristin J Krosschell, John T Kissel, Elise L Townsend, et al.
Page
of 9